Saphnelo is the first therapy in over a decade for patients with moderate to severe systemic lupus erythematosus
Lilly’s tirzepatide doesn’t necessarily top diabetes rivals Jardiance and Ozempic, ICER says fkansteiner Wed, 02/16/2022 – 11:57
A new study adds to a growing body of evidence that organoids — lab-grown collections of cells that […]
Scientists have developed mathematical models that act as patient ‘surrogates’ for evaluating potential prostate cancer treatments.
An interim analysis of an ongoing Phase III study from UCLA Jonsson Comprehensive Cancer Center indicates that using […]
A reduced risk of infection and, as a consequence, a decrease in new infections are goals that have […]
England has followed Scotland and Wales in announcing that all children aged 5-11 years will be offered the […]
Indoor mask mandates are being abandoned in jurisdictions across the United States as politicians grappling with pandemic fatigue […]
People who had been fully vaccinated against covid-19 were around half as likely to develop long covid symptoms […]
